Garima Baral

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 07, 2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.

|Apr 11, 2026
Suppression of PP2A-B56α drives EMT in EGFR mutant non-small cell lung cancer.

Brittany N Heil, Garima Baral, Claire M Pfeffer

|Aug 12, 2025
PP2A activation drives aberrant macropinocytosis and cell death in pancreatic ductal adenocarcinoma.

Garima Baral, Claire M Pfeffer, Sara N Filippelli

|Oct 24, 2024
KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.

Samantha L Tinsley, Ella Rose D Chianis, Rebecca A Shelley

|Aug 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark.

Luopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo

Pageof 1

Frequent Collaborators

4 joint publications

Brittany L Allen-Petersen

2 joint publications

Sydney J Clifford

2 joint publications

Brittany N Heil

2 joint publications

Claire M Pfeffer